Avidity Biosciences, Inc. (RNA)
72.16
-0.01
(-0.01%)
USD |
NASDAQ |
Dec 30, 16:00
72.16
0.00 (0.00%)
After-Hours: 20:00
Avidity Biosciences EPS Diluted (Quarterly): -1.265 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Novartis AG | 2.020 |
| Dyne Therapeutics, Inc. | -0.7619 |
| EXACT Sciences Corp. | -0.1035 |
| Astria Therapeutics, Inc. | -0.5455 |
| Intellia Therapeutics, Inc. | -0.9196 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -174.44M |
| Revenue (Quarterly) | 12.48M |
| Total Expenses (Quarterly) | 186.92M |
| Enterprise Value | 9.048B |
| Gross Profit Margin (Quarterly) | 91.54% |
| Profit Margin (Quarterly) | -1.40K% |
| Earnings Yield | -5.78% |
| Normalized Earnings Yield | -5.779 |